Overview A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial Rhytides Status: Completed Trial end date: 2016-04-26 Target enrollment: Participant gender: Summary This is a safety and efficacy study of onabotulinumtoxinA in subjects with forehead and glabellar facial rhytides (frown lines). Phase: Phase 3 Details Lead Sponsor: AllerganTreatments: abobotulinumtoxinABotulinum ToxinsBotulinum Toxins, Type AincobotulinumtoxinAonabotulinumtoxinA